Zalmox-TM Eye Drops

MRP :

₹165.00

Category

ZALMOX-TM Eye Drops combine Moxifloxacin 0.5% and Tobramycin 0.3% to treat ocular infection effectively, significantly decreasing the frequency of infectious keratitis after LASIK compared to Tobramycin monotherapy. BKC-free. Manufactured in India under WHO-GMP standards. Bulk and export enquiries welcome.

Composition & Packing

CompositionMoxifloxacin 0.5% w/v + Tobramycin 0.3% w/v IP
Packing5ml
Facebook
Twitter
LinkedIn

About Zalmox-TM Eye Drops

Zalmox-TM Eye Drops are an ophthalmic formulation containing Moxifloxacin 0.5% w/v and Tobramycin 0.3% w/v. I Smith welcomes manufacturing and business enquiries from pharmaceutical distributors, PCD franchise partners, institutional buyers and pharmaceutical marketing companies in India.

This page is intended for pharmaceutical trade and manufacturing enquiries. It does not offer direct online sale of prescription medicine to individual customers.

How It Works

  • Moxifloxacin — a fourth-generation, 8-methoxy fluoroquinolone with bactericidal activity; disrupts bacterial replication by inhibiting enzymes like DNA gyrase (topoisomerase II) and topoisomerase IV, showing superior activity compared with ciprofloxacin against quinolone-resistant strains of S. aureus
  • Tobramycin — an aminoglycoside antibiotic with a broad antibacterial spectrum; acts by binding to the 30S and 50S ribosomal subunits, disrupting bacterial protein synthesis, and is significantly more effective than gentamicin sulphate against combined conjunctival pathogens

Indications

  • Bacterial conjunctivitis
  • Post-operative and post-LASIK prevention from vision-threatening bacterial infections

Why Source ZALMOX-TM from I Smith

  • WHO-GMP certified manufacturing unit in Baddi, Himachal Pradesh
  • BKC-free formulation
  • Competitive bulk and wholesale pricing
  • Consistent batch quality with full documentation support
  • Third-party / contract manufacturing available
  • Pan-India and export supply capability

Frequently Asked Questions

What is ZALMOX-TM Eye Drops used for?
It is used for bacterial conjunctivitis and for post-operative or post-LASIK prevention from vision-threatening bacterial infections.

Why combine Moxifloxacin and Tobramycin?
Moxifloxacin, a fourth-generation fluoroquinolone, and Tobramycin, an aminoglycoside, work through different mechanisms of bacterial disruption, offering broader combined coverage and significantly decreasing infectious keratitis frequency after LASIK compared to a single antibiotic alone.

What is the composition and packing of ZALMOX-TM Eye Drops?
Each ml contains Moxifloxacin 0.5% w/v and Tobramycin 0.3% w/v IP, in a 5ml bottle.

Is ZALMOX-TM available for bulk or export orders?
Yes, I Smith supplies ZALMOX-TM Eye Drops in bulk for domestic distribution and export, along with third-party manufacturing options.

Bulk Order & Manufacturing Enquiry

Planning to stock Zalmox-TM Eye Drops for your pharmacy or distribution network? Use the Enquire Now form below to send us your requirement or drop us a message on WhatsApp or simply call +91 98759 13317. Our team will get back to you with pricing, MOQ and product documentation.

Disclaimer: I Smith is an Ophthalmic pharmaceutical manufacturing company in India, providing B2B business solutions. Our ophthalmic products are meant for hospitals, distributors and pharmacies and are not sold directly to individual consumers.

Brand

ismith

Composition

MOXIFLOXACIN 0.5% W/V + TOBRAMYCIN 0.3 % W/V IP

Pack Size

5ML

Pack Type

NA

Scroll to Top
LET'S TALK
Contact Us & Get In Touch here !